
|Articles|January 2, 2004
- Pharmaceutical Technology-01-02-2004
- Volume 28
- Issue 1
Medicare Bill Contains Significant Changes for Drug Manufacturers
Author(s)Jill Wechsler
The new Medicare bill affects pricing and coverage, revises payment formula, and clarifies generic patent issues.
Advertisement
Articles in this issue
over 22 years ago
Coprocessed Excipients for Solid Dosage Formsover 22 years ago
Manufacturing Execution Systemsover 22 years ago
State-of-the-Art Packaging Machinesover 22 years ago
January 2004over 22 years ago
The Bioterrorism Actover 22 years ago
New Supply-Chain Dynamicsover 22 years ago
In the Spotlight--February 2004over 22 years ago
January 2004Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What FDA's AI Warning Letter Tells Us About GMP Accountability
2
Why Are Drugmakers Racing to Acquire ADC Payload Platforms?
3
Preparing for Pharma’s “Y2K Moment”: What the Shift to a 12-Digit NDC Means for Manufacturers
4
The Evolving World of Counterfeit Drugs...Where Does Serialization Fit?
5




